Streetwise Reports' Article Archives — August 2017 back to current month (66)
Ron Struthers, editor of Struther's Resource Stock Report, profiles a zinc company that he is bullish on.
Good News for Chile, Bad News for the US (08/31/2017)
Technical analyst Clive Maund analyzes why the rising copper price is good news for Chile.
With oil and gas prices not easy to predict, Samuel Pelaez, chief investment officer and portfolio manager of Galileo Funds, explains the algorithms that track "quantamentals," and discusses several companies that he expects to outperform.
A past-producing mine in Arizona comes back to life with a new, well-financed and disciplined management team.
Jason Kolbert, analyst with Maxim Group, assesses the billion-dollar transaction that would bring Kite Pharma and the earning potential of its cell therapy programs under the larger biotech's umbrella.
Cerro Las Minitas Showing Its Polymetallic Potential (08/30/2017)
Caesars Report editor Thibaut Lepouttre outlines the latest developments in exploration and assays at the company's flagship project, including numbers that showcase the deposit's polymetallic potential.
Uranium Summer Drilling 'Continues to Impress' (08/29/2017)
Uranium exploration in the Athabasca Basin has revealed promising results for expansion, two industry analysts say.
A Very Good Day for Gold (08/29/2017)
Clive Maund analyzes what happened yesterday in the gold market.
This Canadian miner broke ground on development of its flagship gold project, paving the way for commencement of production in 2019, and also has stepped up exploration on a neighboring prospect.
New Maiden Resource Could Lift Value of Gold Miner (08/28/2017)
Analyst Andrew Kaip with BMO Capital Markets upgraded his rating and target price on this Canadian gold company after modeling the impact of an upcoming estimated resource on its overall production.
Shifting the Narrative (08/28/2017)
Precious metals expert Michael Ballanger discusses gold's breakout and its correlation to the U.S. dollar and cryptocurrencies.
Valuations Hinder Corporate Moves (08/28/2017)
Money manager Adrian Day updates some global equities in his portfolio.
A Critical Q&A with MGX Minerals CEO Jared Lazerson (08/27/2017)
With a lot of activity happening at MGX Minerals, The Critical Investor sat down with CEO Jared Lazerson for a company update.
Jack Chan's Weekly Gold and Silver Market Update (08/26/2017)
Technical analyst Jack Chan charts the latest moves in the precious metals markets.
A site visit to a copper-gold project in northern British Columbia has two analysts speaking highly of this exploration company.
Investors are watching closely for Q2 results due out next week for this commercial solar energy provider that continues to grow with large projects in Canada and the U.S.
A miner with spending money just increased its fleet and made another giant leap forward in expanding its already producing Nevada project.
A regenerative medicine company has signed on to the ThawSTAR Early Adopter Program, a move analyst Douglas Loe of Echelon Wealth Partners terms "positive logistically" to development risk.
Silver Surging: Price Gains Unleashed (08/22/2017)
Silver is cheap and will outperform all other metals, says Lior Gantz, founder of Wealth Research Group, and highlights one company he expects to do well.
Hard Slog in Indonesia, Excitement in Quebec (08/22/2017)
Money manager Adrian Day discusses what's new at three resource companies in his portfolio.
Bob Moriarty of 321 Gold delves into Artemis Resources, Novo Resources' JV partner at Karratha in Australia.
Gold Stock Soars 74% on Release of Drill Results (08/21/2017)
With the release of drill results from this Bulgarian explorer, a pair of analysts expected the market would take notice. They were right.
BMO Capital Markets analyst Andrew Kaip made the case for adding this miner to his firm's coverage universe.
Jack Chan's Weekly Precious Metals Market Update (08/20/2017)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets.
The Bear Market in Oil Continues (08/20/2017)
Technical analyst Jack Chan charts the latest moves in the multiyear bear market in oil and gas.
Medical Cannabis Innovator Set to Go Public (08/18/2017)
A licensed producer of medical cannabis in Canada will begin trading on the Canadian Securities Exchange on Aug. 21.
Summer is the season for drilling, and with the uptick in the precious metals market since 2016, companies are finally able to have the budgets to properly explore their prospects, says Brien Lundin, editor of Gold Newsletter and organizer of the annual New Orleans Investment Conference. Positive results can mean a bump up in share prices, and Lundin discusses six companies that have been releasing good news this summer.
As the drills turn in Quebec this summer, the results released by one explorer are gaining the attention of several experts.
Is the Next Gold Mine in Bulgaria? (08/17/2017)
While Bulgaria may not be the first country investors equate with gold mining, executives at one TSX Venture Exchange-listed company are sitting on pins and needles waiting for the drill results that could prove their high-grade thesis.
A Midsummer Night's Dream: Buy Precious Metals (08/17/2017)
Precious metals expert Michael Ballanger discusses the seasonality of gold and silver, and the metals' relationship with Bitcoin.
Money manager Adrian Day discusses new developments at three of the miners in his portfolio.
Analyst Ram Selvaraju with H.C. Wainwright & Co. provided an update on this biotech company's REVEAL clinical programs, as well as Q2/17 earnings that exceeded expectations.
In an update on this company's clinical cell therapy programs targeting blood cancers and osteoarthritis in the knee, Gabrielle Zhou of Maxim Group describes progress that sets the stage for "value inflection."
Maxim Raises Target Price of Biotech Company (08/16/2017)
A year-over-year increase in sales of its flagship product, and the prospect that its technology could be used to promote the efficacy of cell therapies, helped spur a target price increase on this biotech.
A Critical Q&A with Nemaska Lithium CEO Guy Bourassa (08/16/2017)
The Critical Investor sits down with Nemaska Lithium CEO Guy Bourassa to discuss the company's latest financing, plant construction and mine development.
Good News, Bad News and Encouraging News (08/16/2017)
Money manager Adrian Day presents updates on three precious metal companies in his portfolio.
China, Gold and the US Dollar (08/15/2017)
Clive Maund analyzes where the price of gold will go when China backs the yuan with it.
Andrew Kaip, an analyst with BMO Capital Markets, reviewed this senior mining company's Q2/17 financial highlights and project milestones.
Bet on the Jockey, not the Horse (08/15/2017)
Bob Moriarty of 321 Gold explains why in some cases—and particularly in the case of this explorer—you don’t need to know all the details, you just need to know the geologist.
Cryptocurrencies Exploding: This Is Nuts (08/15/2017)
Cryptocurrencies are a megatrend, says Tom Beck, founder of Portfolio Wealth Global, and discusses their meteoric rise.
11 Opportunities in Gold, Uranium and Diamonds (08/14/2017)
Former journalist James Kwantes, editor of Resource Opportunities, provides a tour of promising junior mining opportunities, from the extremes of northern Canada to the tropics of French Guiana.
Fanciful Fed Follies (08/14/2017)
Precious metals expert Michael Ballanger discusses the gold COT report and its implications for the metal.
Jack Chan's Weekly Precious Metals Update (08/13/2017)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets.
North Korea Showdown: Pivotal Turning Point (08/13/2017)
The next two weeks could be a make-or-break period for President Trump, says Lior Gantz, founder of Wealth Research Group.
Still Good Values Despite High Market (08/13/2017)
Money manager Adrian Day updates developments at several companies in his portfolio.
One uranium producer and explorer reported Q2/17 results that led one analyst to increase its target price.
Andrew Kaip, an analyst with BMO Capital Markets, detailed this royalty company's Q2/17 financial results and relayed its expected production for the full year.
Cell Therapy for Melanoma Impresses in
Phase 2 (08/09/2017)
Positive clinical data for this U.S. company's immunotherapy for metastatic melanoma are both encouraging and impressive, says one analyst.
With the launch of its over-the-counter combination treatment for joint pain and new licensing agreements for feminine lubrication product Zestra, this San Diego-based company is expanding both its therapeutic and international reach.
Explorer's Peruvian Zinc Asset Gets a Critical Look (08/09/2017)
The Critical Investor provides an in-depth update for Ayawilca, noting drilling solidifies the South Zone resource potential for this explorer, while Zone 3 is 'no slam dunk yet,' and results from targets in other zones have yet to be released.
Novo Releases Better Gold Results than the Wits (08/09/2017)
Just back from a tour of Novo Resources' new Karratha projects in Australia, Bob Moriarty of 321 Gold discusses the high-grade potential of the area.
Running Out of Gold: Buyout Phase Imminent (08/08/2017)
Peak gold production may be at hand, says Tom Beck, founder of Portfolio Wealth Global, and explains why he believes the market has entered the buyout phase.
Geologist Dave Mathewson has 35 years of exploration experience in Nevada. In his latest venture, he leads the district-scale exploration that represents his best guess as to where the next major Nevada gold deposit could be found.
A Calgary-based company is positioned to provide energy storage solutions to Hawaii's burgeoning renewable energy market, and the company's recent big order from Australia boosted its order book.
Exploration Is Risky, People Are Not (08/07/2017)
Lior Gantz, founder of Wealth Research Group, explains why the gold exploration sector is worth taking a look at now.
Smartcool Is Really Cool (08/07/2017)
A new device for air conditioners positions this company in ten-bagger territory, says Bob Moriarty of 321Gold.
A drug developer working on a treatment for concussions expects to begin trading on the TSX Venture Exchange on Aug. 8.
Jack Chan's Weekly Precious Metals Update (08/05/2017)
Technical analyst Jack Chan charts the past week in gold and silver.
U.S. Dollar: This Crash Signals the End (08/04/2017)
As the Dow breaches 22,000 and the U.S. dollar slides, Lior Gantz, founder of Wealth Research Group, discusses portfolio positioning.
Horizontal Well in Permian Basin Completed (08/03/2017)
A high-growth oil and gas exploration and production company drilled the first horizontal well on its Permian Basin acreage.
Long-Awaited Drilling in Sumatra Commences (08/03/2017)
A Calgary-based oil and gas exploration and production company announced that drilling has begun on its Sumatran property.
Analysts following a Canadian company that recently released a preliminary economic assessment of its uranium prospects in the Athabasca Basin are all aglow with the results.
Kenneth Ameduri, founder of Crush the Street, discusses why he believes now is a good time to take advantage of cannabis investing opportunities.
On the heels of this precious metals mining company releasing its quarterly results, Andrew Kaip with BMO Capital Markets recapped them for investors.
Brian Marckx, analyst with Zacks Small-Cap Research, reports that a $20 million loan received by a U.S.-based medical device company could further fuel growth.
Surface sampling at a Northwest Territories gold and silver property, located in the shadow of several large past-producing mines, has revealed some high-grade results.
|"DRRX's Phase 2b DUR-928 AH trial is set to begin in mid-2020."|
|"We came away from a site visit to LIO's Tuvatu very impressed."|
|"Drill results highlight the upside potential at MAG's Juanicipio."|
|"TRCH stock wants to break out."|
|"We are initiating coverage on ELY with an Outperform rating."|